LifeStance Health Group, Inc.
LFST Healthcare Medical Care Facilities
LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.
- Revenue
- +25.3%
- EPS
- +2,042.9%
- Free cash flow
- +31.6%
- Total debt
- −5.15%
Quarter to September 2026, against a year earlier
Follow LFST
Alert me
LifeStance Health Group, Inc. (LFST) Revenue
LifeStance Health Group, Inc.'s revenue for fiscal 2025 was $1.4B, up 13.9% from $1.3B in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.7B. Over the past ten years it has ranged from $212.5M (fiscal 2019) to $1.4B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 6 consecutive fiscal years. LifeStance Health Group, Inc. ranks 24th of 47 Medical Care Facilities companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $1.4B | 13.85% |
| FY2024 | $1.3B | 18.50% |
| FY2023 | $1.1B | 22.82% |
| FY2022 | $859.5M | 28.77% |
| FY2021 | $667.5M | 76.96% |
| FY2020 | $377.2M | 77.50% |
| FY2019 | $212.5M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $455.9M | 4.71% |
| Jun 2026 | $435.4M | 7.90% |
| Mar 2026 | $403.5M | 5.57% |
| Dec 2025 | $382.2M | 5.05% |
| 23 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| OPCH Option Care Health, Inc. compare | $5.8B |
| PACS PACS Group, Inc. compare | $5.7B |
| ACHC Acadia Healthcare Company, Inc. compare | $3.4B |
| SGRY Surgery Partners, Inc. compare | $3.4B |
| CHE Chemed Corporation compare | $2.7B |
| AVAH Aveanna Healthcare Holdings Inc. compare | $2.6B |
| CON Concentra Group Holdings Parent, Inc. compare | $2.3B |
| LFST LifeStance Health Group, Inc. | $1.7B |
| NHC National HealthCare Corporation compare | $1.6B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on LFST
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement